Prime Medicine News

Prime Medicine | PRE 14A: Preliminary proxy statements relating to merger or acquisition

04:10

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Director Marrazzo Jeffrey D

Mar 5 10:21

Prime Medicine | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Mar 1 21:14

Prime Medicine | 10-K: Annual report

Mar 1 21:06

Prime Medicine | 8-K: Current report

Mar 1 21:06

Prime Medicine | 3: Initial statement of beneficial ownership of securities- GV 2023 GP, L.L.C.

Mar 1 05:28

Prime Medicine | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Alphabet Holdings LLC(12.2%),XXVI Holdings Inc.(12.2%), etc.

Mar 1 05:21

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Gottesdiener Keith Michael

Feb 27 22:40

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Goldwasser Meredith

Feb 24 06:12

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer LEE ANN L.

Feb 24 06:12

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Duffield Jeremy

Feb 24 06:12

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Brudnick Richard

Feb 24 06:10

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Officer Alenson Carman

Feb 24 06:06

Prime Medicine | SC 13D: Statement of acquisition of beneficial ownership by individuals-ARCH Venture Fund X, L.P.(12.9%),ARCH Venture Fund X Overage, L.P.(12.9%), etc.

Feb 23 10:33

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-Director NELSEN ROBERT

Feb 21 06:44

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Partners XII, LLC

Feb 21 06:44

Prime Medicine | 4: Statement of changes in beneficial ownership of securities-10% Owner ARCH Venture Partners X, LLC

Feb 21 06:40

Prime Medicine | 8-K: Current report

Feb 16 19:26

Prime Medicine | 424B5: Prospectus

Feb 16 19:21

Prime Medicine | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Feb 15 19:07